Cargando…

PM432. Evaluation of the extrapyramidal side effects (EPS) liability of NMDA receptor glycine-binding site agonists

Detalles Bibliográficos
Autores principales:	Ohno, Yukihiro, Fujii, Syodai, Inada, Akiyoshi, Sato, Yuka, Shimizu, Saki, Sogabe, Syunsaku, Takasaki, Haruna, Wakamatsu, Ryo, Yamanaka, Megumi, Yanagisako, Ryoto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616367/ http://dx.doi.org/10.1093/ijnp/pyw041.432

Ejemplares similares

Glycine-Binding Site Stimulants of NMDA Receptors Alleviate Extrapyramidal Motor Disorders by Activating the Nigrostriatal Dopaminergic Pathway
por: Shimizu, Saki, et al.
Publicado: (2017)

PS121. Evaluation of extrapyramidal side effects in the treatment of behavioral and psychological symptoms of dementia (BPSD): Interactions between anti-Alzheimer drugs and antidepressants
por: Shimizu, Saki, et al.
Publicado: (2016)

Antipsychotic Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD): Management of Extrapyramidal Side Effects
por: Ohno, Yukihiro, et al.
Publicado: (2019)

Glycine-dependent activation of NMDA receptors
por: Cummings, Kirstie A., et al.
Publicado: (2015)

Involvement of NMDA receptors in tremor expression in Aspa/Hcn1 double-knockout rats
por: Nishitani, Ai, et al.
Publicado: (2020)

New engineering techniques used in a high-power model of the 432 MHz DTL
por: Naito, F, et al.
Publicado: (1995)

Drug-Induced Extrapyramidal Syndromes
por: Lader, M. H.
Publicado: (1970)

Escitalopram-induced extrapyramidal symptoms
por: Kumar, Pattath Narayanan Suresh, et al.
Publicado: (2019)

rf characteristics of a high-power model of the 432 MHz DTL
por: Naito, F, et al.
Publicado: (1995)

Slovenian Version of the Drug-Induced Extrapyramidal Symptoms Scale: Evaluation of Interrater and Test-Retest Reliability
por: Senica, Nina, et al.
Publicado: (2023)

NMDA receptor activation induces long-term potentiation of glycine synapses
por: Kloc, Michelle L., et al.
Publicado: (2019)

Genetic Variants in Diseases of the Extrapyramidal System
por: Oczkowska, Anna, et al.
Publicado: (2014)

Akathisia as an Extrapyramidal Side Effect of Fluoxetine
por: Ajufo, Ijeoma, et al.
Publicado: (2021)

First operation of a 432-MHz, 3-MeV RFQ stabilized with PISLs
por: Ueno, A, et al.
Publicado: (1995)

Drug-induced Extrapyramidal Symptoms Scale (DIEPSS) Serbian Language version: Inter-rater and Test-retest Reliability
por: Peljto, Ami, et al.
Publicado: (2017)

FLUOXETINE INDUCED EXTRAPYRAMIDAL SYMPTOMS : CASE REPORTS
por: Nizamie, S. Haque, et al.
Publicado: (1998)

Extrapyramidal side effects with low doses of amisulpride
por: Mandal, Nikhiles, et al.
Publicado: (2014)

Second-Generation Antipsychotics and Extrapyramidal Adverse Effects
por: Divac, Nevena, et al.
Publicado: (2014)

Dothiepin-induced transient hypomania and extrapyramidal syndrome
por: Inamdar, Amir, et al.
Publicado: (2013)

MICU1- Related Myopathy with Extrapyramidal Signs
por: Mukherjee, Debaleena, et al.
Publicado: (2023)

Chronic subdural haematoma mimicking extrapyramidal symptoms
por: Cheng, Po Wen, et al.
Publicado: (2023)

High-power test of a 432-MHz, 3-MeV RFQ stabilized with PISLs
por: Ueno, A, et al.
Publicado: (1995)

Dual Allosteric Effect in Glycine/NMDA Receptor Antagonism: A Comparative QSAR Approach
por: Sharma, Manish, et al.
Publicado: (2010)

Differential regulation of NMDA receptors by d-serine and glycine in mammalian spinal locomotor networks
por: Acton, David, et al.
Publicado: (2017)

NMDA Receptor Glycine Binding Site Modulators for Prevention and Treatment of Ketamine Use Disorder
por: Hsiao, Yu-Chin, et al.
Publicado: (2023)

Extrapyramidal signs in normal pressure hydrocephalus: an objective assessment
por: Mandir, Allen S, et al.
Publicado: (2007)

Genetics of Parkinson's Disease and Other Diseases of the Extrapyramidal System
por: Dorszewska, Jolanta
Publicado: (2014)

Possible sertraline-induced extrapyramidal adverse effects in an adolescent
por: Wang, Lian-fang, et al.
Publicado: (2016)

Severe Extrapyramidal Syndrome Caused by Lurasidone Low Dose
por: Das, Soumitra, et al.
Publicado: (2018)

Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychotics
por: Boloc, Daniel, et al.
Publicado: (2018)

Genotype, extrapyramidal features, and severity of variant ataxia‐telangiectasia
por: Schon, Katherine, et al.
Publicado: (2019)

Post-Mumps Extrapyramidal Syndrome in a Young Child
por: Verma, Rajesh, et al.
Publicado: (2021)

Acute Extrapyramidal Side Effects from Smoked Haloperidol
por: Pham, Angeline, et al.
Publicado: (2021)

Brainstem atrophy is linked to extrapyramidal symptoms in frontotemporal dementia
por: Heikkinen, Sami, et al.
Publicado: (2022)

Extrapyramidal syndrome in psychotic depression: a case report.
por: Álvarez, C., et al.
Publicado: (2023)

Nuclear liability
por: Weinstein, Jerry L
Publicado: (1962)

Liability of Hospitals
Publicado: (1909)

The Employer's Liability
Publicado: (1921)

Liability of Dentists
Publicado: (1883)

Liabilities of Patients
Publicado: (1890)

Cannot write session to /tmp/vufind_sessions/sess_b0uopdnsirln82l9ce9ubio91j